Teach me all about radiology of all types of ILD how to diagnose what are the appearance s

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
Loading Image
Loading Image
I now have rich, comprehensive content from multiple authoritative textbooks and real CT images. Let me compile the complete, detailed response.

Radiology of Interstitial Lung Disease (ILD): A Complete Guide

Sources: Grainger & Allison's Diagnostic Radiology, Murray & Nadel's Textbook of Respiratory Medicine, Goldman-Cecil Medicine, Fishman's Pulmonary Diseases & Disorders

Part 1: Framework - How to Approach ILD Radiology

Imaging Modality Hierarchy

Chest X-ray (CXR) is the first step but is insensitive. It may be normal in up to 10% of ILD patients. Its main value is suggesting a category and assessing progression. It cannot replace HRCT.
High-Resolution CT (HRCT) is the gold standard. It:
  • Increases diagnostic accuracy from 27% (clinical alone) to 61% when added to clinical data and CXR
  • Distinguishes reversible (ground-glass, active inflammation) from irreversible (honeycombing, fibrosis) changes
  • Guides bronchoalveolar lavage (BAL) and biopsy site selection
  • Monitors treatment response
  • In UIP/IPF, a typical pattern on HRCT can obviate surgical lung biopsy
Technical points: Use 1-mm thin sections. Prone images help distinguish posterior fibrosis from gravitational atelectasis. Expiratory images reveal air trapping (reflecting small airways disease).

Part 2: The HRCT Pattern Dictionary

Before going disease by disease, you must master these key HRCT patterns:
PatternWhat it looks likeWhat it means
Ground-glass opacity (GGO)Hazy increased density, vessels still visibleActive inflammation, usually reversible
Reticular patternNetwork of fine lines (intralobular septa)Fibrosis, thickened septa
HoneycombingClustered thick-walled cysts (3-10mm), subpleural, stacked layersIrreversible end-stage fibrosis (UIP hallmark)
Traction bronchiectasisDilated, irregular airways within fibrotic lungIrreversible fibrosis pulling airways open
ConsolidationComplete airspace opacification, air bronchogramsAlveolar filling (COP, AIP, eosinophilic pneumonia)
Centrilobular nodulesSmall nodules <5mm, not reaching pleuraCellular bronchiolitis, HP, RB-ILD
Perilymphatic nodulesAlong bronchovascular bundles, fissures, septaSarcoidosis, lymphangitic carcinomatosis
Mosaic attenuationGeographic areas of different densityAir trapping, vascular disease, or infiltration
Air trapping (expiratory)Areas stay dark on expirationSmall airways disease
Thin-walled cystsDiscrete cysts, no surrounding fibrosisLAM, LCH, LIP

Part 3: Idiopathic Interstitial Pneumonias (IIPs)

The ATS/ERS classification divides IIPs into several entities. Each has a characteristic CT signature.

1. Idiopathic Pulmonary Fibrosis (IPF) / Usual Interstitial Pneumonia (UIP)

IPF is the most common and most lethal IIP. The underlying pattern is UIP. HRCT is so characteristic it can often confirm the diagnosis without biopsy.

The 4 HRCT Categories (ATS/ERS/JRS/ALAT 2018 + Fleischner Society 2018):

Typical UIP pattern - virtually pathognomonic for IPF:
  • Predominantly subpleural, bibasal reticular pattern
  • Honeycombing (thick-walled cysts in stacked layers)
  • Traction bronchiectasis and bronchiolectasis
  • The disease "creeps" up the periphery in a "propeller blade" distribution on sagittal images
  • GGO is NOT dominant; when present, it is surrounded by traction bronchiectasis (indicating fibrosis, not activity)
  • No features suggesting alternative diagnosis
Probable UIP pattern (biopsy may still be avoided with right clinical context):
  • Subpleural bibasal reticular pattern
  • Peripheral traction bronchiectasis/bronchiolectasis
  • No honeycombing
  • Reflects definite/probable UIP pathology in 82-94% of cases
Indeterminate for UIP (requires biopsy):
  • Subtle reticulation; may have mild GGO
  • No distribution that fits typical/probable
  • No features inconsistent with UIP
CT pattern inconsistent with UIP (alternative diagnosis):
  • Upper or mid-lung predominant fibrosis
  • Peribronchovascular predominance
  • Extensive GGO (>extent of reticulation)
  • Profuse micronodules, discrete cysts away from honeycombing zones
  • Diffuse air trapping (mosaic pattern)
  • Consolidation in bronchopulmonary segment/lobe
Fig. 9.1 - Typical UIP/IPF: axial HRCT showing subpleural honeycombing and reticular pattern at the lung bases with traction bronchiectasis; sagittal showing the "propeller blade" peripheral distribution creeping toward upper lobes.
Typical UIP/IPF CT pattern - subpleural honeycombing, reticular changes, traction bronchiectasis at lung bases with "propeller blade" distribution on sagittal view
Fig. 9.2 - Probable UIP: subpleural basal reticulation with peripheral traction bronchiolectasis, no honeycombing. Bronchiolectasis characteristically originates at the posterior costophrenic sulcus.
Probable UIP CT pattern - subpleural reticulation with peripheral traction bronchiectasis, no honeycombing
Honeycombing vs mimics - this is clinically critical:
Honeycombing vs mimics including LAM, paraseptal emphysema, cystic bronchiectasis - comparison panel showing thick-walled clustered subpleural cysts vs thin-walled scattered cysts
Key distinguishing points:
  • True honeycombing: thick-walled cysts, subpleural, stacked in layers, always with other fibrotic features (traction bronchiectasis, architectural distortion)
  • Paraseptal emphysema: thin-walled, single layer subpleural, no fibrotic features
  • LAM cysts: randomly scattered, normal lung between cysts, no subpleural predominance, no fibrosis
  • Cystic bronchiectasis: centrally located, along vessels, tubular shape

2. Nonspecific Interstitial Pneumonia (NSIP)

NSIP is the most common IIP pattern in connective tissue diseases (CTD). It has a better prognosis than IPF.
HRCT features:
  • Bilateral symmetric ground-glass attenuation - the dominant finding
  • Peripheral, subpleural, lower-lobe predominance
  • Subpleural sparing - a characteristic and distinctive feature (unlike UIP)
  • Irregular lines and mild reticulation
  • Occasional consolidation
  • Traction bronchiectasis when fibrotic NSIP
  • Honeycombing rare (if present, indicates fibrotic NSIP, worse prognosis)
CXR: Bilateral ground-glass and reticular opacification, basal predominance.
Key distinction from UIP: NSIP shows more GGO and less honeycombing; subpleural sparing helps.

3. Cryptogenic Organizing Pneumonia (COP)

COP (formerly BOOP) has a distinctive CT pattern. It often responds well to corticosteroids, but lesions can recur.
HRCT features:
  • Patchy bilateral consolidation - most characteristic
  • Distribution: subpleural or peribronchial (peribronchovascular)
  • Air bronchograms within consolidation
  • Lower lobe predominance
  • "Reversed halo sign" (atoll sign): crescent or ring of consolidation around central GGO - highly specific for COP
  • Perilobular pattern: band-like consolidation along lobular borders
  • Migration of lesions over time ("migratory infiltrates")
  • GGO with traction bronchiectasis may be present in fibrotic COP
CXR: Bilateral patchy consolidation, may be fleeting/migratory on serial films.

4. Acute Interstitial Pneumonia (AIP) / Diffuse Alveolar Damage (DAD)

AIP is the idiopathic form of ARDS. It is histologically DAD and clinically presents as rapidly progressive respiratory failure.
HRCT features (evolve through phases):
  • Exudative phase (days 1-7): Bilateral diffuse GGO and consolidation, often with lobular sparing (geographic distribution)
  • Organizing phase (weeks 2-4): Traction bronchiectasis develops within GGO (hallmark of transition to fibrosis)
  • Dependent consolidation common
  • Anterior-posterior density gradient (dependent vs. non-dependent)
  • Architectural distortion in fibrotic phase
CXR: Bilateral diffuse ground-glass density or consolidation (similar to cardiogenic pulmonary edema).

5. Respiratory Bronchiolitis-ILD (RB-ILD)

Strongly associated with heavy cigarette smoking. Often an incidental finding.
HRCT features:
  • Diffuse, patchy ground-glass opacification due to macrophage accumulation
  • Poorly defined centrilobular nodules (fluffy, low-attenuation)
  • Upper lobe predominance (bilateral, symmetric)
  • Centrilobular emphysema (related to smoking)
  • Areas of air trapping
  • Interlobular septal thickening and interstitial fibrosis may occur but are not dominant
  • Normal CXR in up to 20% of RB-ILD patients

6. Desquamative Interstitial Pneumonia (DIP)

Also smoking-related. More extensive macrophage accumulation than RB-ILD.
HRCT features:
  • Extensive ground-glass opacification - dominant feature
  • Distribution: lower zone, peripheral, may be patchy or geographic
  • Associated reticulation (mild)
  • Small cysts may be present within GGO
  • Features of established fibrosis (architectural distortion, mild bronchiectasis) in some patients
  • Normal CXR in up to 25% of cases
DIP vs RB-ILD: DIP has more extensive GGO (often bilateral and diffuse), while RB-ILD has centrilobular nodules with more upper lobe distribution.
DIP - HRCT showing bilateral lower lobe ground-glass opacification with mild reticulation, progressing to fibrosis over 2 years

7. Lymphoid Interstitial Pneumonia (LIP)

Associated with Sjögren syndrome, HIV, and immunodeficiency states.
HRCT features:
  • Diffuse GGO (dominant)
  • Thin-walled cysts (scattered, often bilateral) - highly characteristic
  • Centrilobular nodules
  • Thickened interlobular septa and bronchovascular wall thickening
  • Lower lobe predominance
Key feature: The combination of GGO + scattered thin-walled cysts in the right clinical context (Sjögren, HIV) is strongly suggestive.

Part 4: Non-Idiopathic ILD

8. Sarcoidosis

Sarcoidosis is the archetypal perilymphatic nodular disease.
CXR Staging (Scadding):
  • Stage 0: Normal
  • Stage I: Bilateral hilar lymphadenopathy (BHL) only
  • Stage II: BHL + parenchymal infiltrates
  • Stage III: Parenchymal infiltrates only (no BHL)
  • Stage IV: Pulmonary fibrosis
Note: Parenchymal changes often appear as BHL is subsiding (unlike lymphoma where they progress together).
HRCT features:
  • Perilymphatic nodules (1-5mm) - along bronchovascular bundles, pleura (including fissures), and interlobular septa - this distribution is the key
  • "Galaxy sign": smaller nodules cluster around a large central nodule - highly specific for sarcoidosis
  • Irregular and beaded interfaces
  • Larger ill-defined nodules ± air bronchograms
  • Patchy GGO
  • Interlobular septal thickening
  • Air trapping - correlates with small airways disease on PFTs
  • Advanced disease: upper/mid-zone fibrosis, traction bronchiectasis, bullae, ring shadowing
  • Progressive massive fibrosis (PMF) - resembling silicosis - in end-stage
Distribution: Mid and upper lobe predominance (bilateral); perihilar in advanced fibrotic disease.
Sarcoidosis HRCT - (A) Perilymphatic nodules along fissures; (B) Galaxy sign (arrow) - cluster of micronodules around a large nodule; (C) Sagittal view showing upper lobe traction bronchiectasis and volume loss in advanced fibrotic sarcoidosis

9. Hypersensitivity Pneumonitis (HP)

Three phases: acute, subacute, chronic. Radiology differs by phase.
Acute HP:
  • Bilateral GGO and consolidation
  • Often resolves spontaneously on antigen removal
Subacute HP (classic HRCT pattern):
  • Diffuse poorly defined centrilobular nodules (3-5mm)
  • Patchy bilateral GGO
  • Air trapping on expiratory CT (lobular or panlobular) - very characteristic
  • Mosaic perfusion - areas of normal and reduced attenuation
  • Mid and upper lobe predominance
  • Head-cheese sign: combination of GGO, normal lung, and air trapping creating three different densities
Chronic HP (fibrotic):
  • Reticulation and fibrosis
  • Upper/mid lobe predominance (differs from IPF which is lower lobe)
  • Traction bronchiectasis
  • May develop honeycombing - can mimic UIP
  • Peribronchovascular distribution (not purely subpleural like UIP)
  • GGO and centrilobular nodules often persist alongside fibrosis (important clue)
CXR: Bilateral GGO and consolidation (acute/subacute); reticulonodular, upper lobe fibrosis (chronic).

10. Connective Tissue Disease-ILD (CTD-ILD)

Most CTDs can cause ILD; they most commonly produce NSIP or UIP patterns.
Rheumatoid Arthritis (RA-ILD):
  • Most common pattern: UIP (more than NSIP, unlike other CTDs)
  • HRCT indistinguishable from idiopathic UIP/IPF
  • Also: bronchiectasis (up to 30%), obliterative bronchiolitis, follicular bronchiolitis, COP pattern, pleural effusions
  • Necrobiotic (rheumatoid) nodules: well-defined, peripheral, may cavitate
Systemic Sclerosis (SSc/Scleroderma):
  • Most common ILD pattern: fibrotic NSIP
  • Subpleural basal GGO with reticulation, subpleural sparing
  • Dilated esophagus on HRCT - a helpful diagnostic clue
  • Pulmonary hypertension disproportionate to fibrosis extent
Polymyositis/Dermatomyositis (PM/DM):
  • Mixed pattern: GGO, reticular, consolidation
  • Both NSIP and COP patterns occur
  • "Mechanic's hands," elevated CK, anti-Jo-1 in some
Sjögren Syndrome:
  • LIP pattern (GGO + thin-walled cysts)
  • Also: follicular bronchiolitis, NSIP
SLE:
  • Acute lupus pneumonitis (bilateral GGO/consolidation)
  • Pleuritis/effusions common
  • Shrinking lung syndrome: small lung volumes, elevated diaphragm

11. Langerhans Cell Histiocytosis (LCH / PLCH)

Almost exclusively in smokers. Distinctive cystic pattern.
HRCT features:
  • Upper and mid-lung predominance (spares costophrenic angles)
  • Bilateral irregular/bizarre-shaped cysts - key feature; cysts vary in size and shape (not all round)
  • Centrilobular nodules (early disease) that cavitate and form cysts (later)
  • Normal lung volumes or hyperinflation
  • Pneumothorax is a recognized complication
Evolution: nodules (early) → cavitating nodules → cysts (late)

12. Lymphangioleiomyomatosis (LAM)

Occurs almost exclusively in women of childbearing age. Associated with tuberous sclerosis.
HRCT features:
  • Bilateral, diffuse, thin-walled, round cysts - uniformly distributed throughout the lung
  • Normal lung intervening between cysts (unlike UIP honeycombing)
  • No subpleural predominance
  • No fibrosis
  • Cysts increase in number/size over time
  • Pleural effusion (chylothorax) may occur
  • Pneumothorax common
Key distinction from UIP honeycombing: LAM cysts are round, thin-walled, uniformly distributed, with no surrounding fibrosis.

13. Asbestosis

Occupational ILD from asbestos exposure (>10 year latency). Pattern mirrors UIP.
HRCT features:
  • Bilateral lower-lobe fibrosis - subpleural, basal (similar to UIP)
  • Reticular pattern, traction bronchiectasis, honeycombing in advanced disease
  • Subpleural dots and lines - early characteristic finding
  • Pleural plaques - calcified or non-calcified, diaphragmatic/posterolateral
  • Pleural thickening (diffuse)
  • Rounded atelectasis ("crow's feet" - curvilinear bands converging on pleura)
The combination of lower lobe fibrosis + pleural plaques strongly suggests asbestosis.

14. Silicosis / Coal Worker's Pneumoconiosis (CWP)

Simple silicosis:
  • Upper lobe nodules (1-10mm) - bilateral, well-defined
  • Perilymphatic distribution (like sarcoidosis)
  • Eggshell calcification of hilar/mediastinal nodes (pathognomonic)
Progressive Massive Fibrosis (PMF):
  • Conglomerate masses (>1cm, usually >2cm) in upper lobes
  • "Egg-in-a-cup" or PMF masses migrating toward hilum
  • Associated emphysema

15. Eosinophilic Pneumonia (Chronic)

HRCT features:
  • Peripheral consolidation and GGO - "photographic negative of pulmonary edema"
  • Upper/mid-lung zone predominance with peripheral distribution
  • Recurrent or migratory lesions (unlike most ILDs)
  • Air bronchograms within consolidation
  • Pleural effusion in ~10%

16. Drug-Induced ILD

Highly variable patterns - virtually any ILD pattern can be drug-induced. Common patterns:
  • Amiodarone: high-density consolidation (due to iodine in drug), peripheral GGO, NSIP pattern
  • Methotrexate: hypersensitivity pattern, GGO, consolidation
  • Chemotherapy (bleomycin, cyclophosphamide): COP pattern, NSIP pattern
  • Nitrofurantoin: pleural effusion + parenchymal infiltrates

Part 5: Chest X-Ray Pattern → Differential Diagnosis

(From Goldman-Cecil Medicine, Table 80-3)
CXR FindingKey Diagnoses
Decreased lung volumesIPF, NSIP, DIP, CTD-ILD, asbestosis, drug-ILD
Preserved/increased volumesIPF+emphysema, LCH, LAM, sarcoidosis, HP, RB-ILD
MicronodulesHP, sarcoidosis, RB-ILD, infection
HoneycombingIPF, fibrotic NSIP, CTD-ILD, asbestosis, chronic HP
Migratory/fleeting infiltratesCOP, HP, eosinophilic, ABPA
Upper lobe predominanceSarcoidosis, HP, LCH, silicosis, ankylosing spondylitis
Lower lobe predominanceIPF, NSIP, CTD-ILD, asbestosis
Peripheral distributionIPF, NSIP, COP, chronic eosinophilic pneumonia
Pleural diseaseCTD, asbestosis, malignancy, LAM, sarcoidosis
PneumothoraxLCH, LAM, tuberous sclerosis
Hilar adenopathySarcoidosis, silicosis, LIP, malignancy
Normal CXRCellular NSIP, RB-ILD, HP, sarcoidosis (up to 10%)

Part 6: Diagnostic Approach Summary

Step 1: Clinical context
   - Age, sex, smoking history, occupation, drug history, CTD symptoms
   - Pace of onset (acute, subacute, chronic)

Step 2: CXR
   - Lung volumes (decreased vs preserved)
   - Distribution (upper/lower, central/peripheral)
   - Pattern (nodular, reticular, consolidation, mixed)
   - Pleural changes, adenopathy

Step 3: HRCT (1mm, prone and expiratory views)
   - Classify dominant pattern (GGO, reticular, honeycomb, nodular, consolidation, cystic)
   - Assess distribution (upper/lower, central/peripheral/subpleural, axial)
   - Look for specific signs (perilymphatic nodules, galaxy sign, reversed halo, subpleural sparing)

Step 4: Multidisciplinary Discussion
   - Radiologist + Pulmonologist + Pathologist
   - Correlate with serology, BAL, PFTs
   - Decide if biopsy is needed or if HRCT pattern is diagnostic

Step 5: Biopsy (if needed)
   - Site guided by HRCT (most active disease, avoid honeycombing/end-stage areas)

Quick Reference: ILD Pattern on HRCT

ILD TypeDominant CT PatternDistributionKey Feature
IPF/UIPReticular + honeycombingSubpleural, bibasalPropeller blade; no GGO dominance
NSIPGGO + reticulationSubpleural, lowerSubpleural sparing
COPConsolidationSubpleural/peribronchialReversed halo sign; migrating
AIPGGO + consolidationDiffuse, bilateralLobular sparing; rapid progression
RB-ILDCentrilobular GGO nodulesUpper lobe, bilateralHeavy smoker; subtle
DIPExtensive GGOLower lobe, peripheralDiffuse; smoker
LIPGGO + cystsLower lobeThin-walled cysts; Sjögren/HIV
SarcoidosisPerilymphatic nodulesUpper/mid lobe, perihilarGalaxy sign; BHL
HP (subacute)GGO + centrilobular nodules + air trappingUpper/mid lobeHead-cheese sign; mosaic
LAMThin-walled cystsDiffuse, uniformYoung women; no fibrosis
LCHNodules → bizarre cystsUpper/mid, spares basesSmokers; irregular cysts
AsbestosisReticular + pleural plaquesLower lobe, subpleuralPleural plaques = clue
SilicosisUpper lobe nodulesUpper lobeEggshell calcification
Chronic eosinophilicPeripheral consolidationUpper/mid, peripheral"Photographic negative of edema"

Sources: Grainger & Allison's Diagnostic Radiology (9780323760751); Murray & Nadel's Textbook of Respiratory Medicine (9780323655873); Goldman-Cecil Medicine (9780323930345); Fishman's Pulmonary Diseases and Disorders (9781260473940)

With tables and flow chart keep all image

Summarise it and make table and keep images

Reading File
Running Command
Running Command
Running Command
I now have all the content I need. Let me compile everything into a comprehensive, well-structured response with tables, flowcharts, and all images preserved.

ILD Radiology: Complete Summary with Tables and Flowcharts

Updated with: ERS/ATS 2025 Statement (Ryerson et al., Eur Respir J 2025) + Grainger & Allison's Diagnostic Radiology + Goldman-Cecil Medicine + Murray & Nadel's Respiratory Medicine

FLOWCHART 1: Overall Diagnostic Approach to ILD

┌─────────────────────────────────────────────────────────────────┐
│        INTERSTITIAL LUNG DISEASE SUSPECTED                       │
│    (dyspnoea, cough, bibasal crackles, restrictive PFTs)        │
└──────────────────────────┬──────────────────────────────────────┘
                           │
                    CHEST X-RAY
                           │
        ┌──────────────────┼──────────────────┐
        ▼                  ▼                  ▼
   Normal (10%)     Reticular/nodular    Consolidation/GGO
        │           lower zones          bilateral
        │                  │                  │
        └──────────────────┼──────────────────┘
                           │
                    ┌──────▼──────┐
                    │  HRCT CHEST │  (1mm sections, prone,
                    │  (KEY STEP) │   expiratory views)
                    └──────┬──────┘
                           │
         ┌─────────────────┼──────────────────┐
         ▼                 ▼                  ▼
   INTERSTITIAL      ALVEOLAR FILLING    COMBINED
   PATTERNS          PATTERNS            PATTERNS
         │                 │                  │
   ┌─────┴─────┐      ┌────┴────┐             │
   Fibrotic    Non-   OP  RB-ILD  AMP         MDD
              Fibrotic rare AFPs
         │
   ┌─────┼──────┐
  UIP   NSIP   BIP   PPFE  LIP  DAD
         │
         ▼
   MULTIDISCIPLINARY DISCUSSION (MDD)
   Clinical + Radiology + Pathology + Lab
         │
         ▼
   ┌─────────────────────────────────────────────┐
   │ DIAGNOSTIC CONFIDENCE                        │
   │  ≥90% → Confident Diagnosis                  │
   │  51-89% → Provisional Diagnosis              │
   │  <50% → Unclassifiable ILD                   │
   └─────────────────────────────────────────────┘

FLOWCHART 2: HRCT Pattern Classification (2025 ERS/ATS Schema)

              HRCT Abnormality Identified
                          │
          ┌───────────────┴───────────────┐
          ▼                               ▼
   INTERSTITIAL                    ALVEOLAR FILLING
   DISORDERS                       DISORDERS
          │                               │
   ┌──────┴──────┐               ┌────────┴────────┐
   │             │               │                 │
Fibrotic    Non-fibrotic      Common              Rare
   │             │               │                 │
┌──┴──┐    ┌────┴────┐     ┌────┴────────┐  ┌────┴────────┐
UIP   NSIP  NSIP   BIP    OP  RB-ILD  AMP  AEP CEP PAP
NSIP  BIP  (cell) (non-        │             Lipoid pn.
BIP   LIP  fibr)  fibrot)
PPFE  DAD                   Subcategories of OP:
                            Multifocal/focal
                            AFOP, CiOP

TABLE 1: Key HRCT Patterns and Their Meaning

HRCT PatternAppearanceWhat It Suggests
Ground-glass opacity (GGO)Hazy increased density; vessels still visibleActive inflammation (usually reversible); when with fibrotic features = irreversible
Reticular patternNetwork of fine intralobular linesFibrosis, interstitial thickening
HoneycombingClustered thick-walled cysts (3-10mm), subpleural, stacked layersIrreversible end-stage fibrosis = UIP hallmark
Traction bronchiectasisIrregular dilated airways within fibrotic zonesFibrosis pulling airways open; irreversible
ConsolidationComplete opacification, air bronchogramsAlveolar filling: COP, AIP, eosinophilic pneumonia
Centrilobular nodulesSmall nodules not reaching pleura (<5mm)Cellular bronchiolitis, HP, RB-ILD
Perilymphatic nodulesAlong bronchovascular bundles, fissures, septaSarcoidosis, silicosis, lymphangitic carcinomatosis
Thin-walled cystsDiscrete cysts, no surrounding fibrosisLAM, LCH, LIP
Mosaic attenuationGeographic areas of different densityAir trapping (HP), vascular disease, combined patterns
Three-density signHigh + normal + low attenuation zonesFibrotic BIP/HP (formerly "typical HP pattern")
Reversed halo signRing of consolidation around central GGOCOP (highly specific)
Galaxy signCluster of micronodules around large noduleSarcoidosis (highly specific)
Subpleural sparingGGO stops before the pleuraFibrotic NSIP (distinguishes from UIP)

TABLE 2: IIP/ILD Classification - 2025 ERS/ATS Update

(Updated from 2013 classification - Ryerson et al., Eur Respir J 2025)
CategoryPatternPrimary (Idiopathic)Secondary Causes
Interstitial - FibroticUIPIPFCTD-ILD, HP, asbestosis, drugs
NSIP (fibrotic)iNSIPCTD-ILD, HP, drugs
BIP (fibrotic)iBIPHP, CTD-ILD, aspiration, occupational
PPFEiPPFECTD-ILD, BMT, drugs
Interstitial - Non-fibroticNSIP (cellular)iNSIPCTD-ILD
BIP (non-fibrotic)iBIPHP, CTD-ILD
DADiDADInfection, CTD, drugs, toxins
LIPiLIPSjögren, HIV, immunodeficiency
Alveolar Filling - CommonOrganising PneumoniaCOPCTD, infection, drugs, radiation
RB-ILDiRB-ILDSmoking (93%), rarely idiopathic
AMP (replaces DIP)iAMPSmoking (81%), CTD, surfactant disorders
Alveolar Filling - RareEosinophilic pneumoniaAEP / CEPDrug, parasites, allergens
PAPIdiopathicGM-CSF autoAb, secondary
Lipoid pneumoniaEndogenousAspiration, inhalation
OtherCombined patterns-Multiple overlapping
Unclassifiable ILD--
Key 2025 changes: "DIP" renamed → Alveolar Macrophage Pneumonia (AMP); "HP pattern" → Bronchiolocentric Interstitial Pneumonia (BIP); new subcategories of OP added (AFOP, CiOP); PPFE promoted from "rare" to "major" pattern

TABLE 3: Radiological Features of All Major ILD Types (Master Reference Table)

ILD TypeCXR FeaturesHRCT Dominant PatternDistributionKey Distinguishing Feature
IPF/UIP (Typical)Basal volume loss, reticularHoneycombing + reticular + traction bronchiectasisSubpleural, bibasal, peripheral"Propeller blade" distribution; NO GGO dominance
IPF/UIP (Probable)Basal reticularReticular + traction bronchiectasis (NO honeycombing)Subpleural, bibasalBronchiolectasis originates at posterior costophrenic sulcus
NSIP (Fibrotic)GGO + reticular, basalGGO + reticulation + traction bronchiectasisLower lobe, peripheral, bilateralSubpleural sparing (distinguishes from UIP); no honeycombing
NSIP (Cellular)GGO predominantGGO, minimal reticulationLower lobe predominantPreserved architecture; responds to immunomodulators
BIP / HP (Non-fibrotic)ReticulonodularCentrilobular GGO nodules + mosaic attenuation + air trappingUpper/mid lobeThree-density sign; centrilobular nodules
BIP / HP (Fibrotic)Upper-mid fibrosisPeribronchovascular GGO + traction bronchiectasis + mosaic + three-density signUpper/mid lobe; diffuse axialThree-density sign; NOT purely subpleural (unlike UIP)
COPPatchy bilateral consolidationConsolidation ± GGO ± perilobular patternSubpleural or peribronchial, lower lobesReversed halo (atoll) sign; migratory infiltrates
AIP/DADBilateral diffuse consolidationBilateral GGO + consolidation ± lobular sparingDiffuse, bilateralRapid progression; traction bronchiectasis in organising phase
RB-ILDSubtle/normal (20% normal)Centrilobular GGO nodules (fluffy, low-attenuation)Upper lobe, bilateralHeavy smoker; poorly defined centrilobular pattern
AMP (was DIP)GGO predominant (25% normal)Extensive GGO ± reticulation ± cystsLower/mid lung, peripheralDiffuse macrophage accumulation; smoker; cysts may form
LIPReticular + nodularGGO + thin-walled scattered cystsBilateral, lower lobeCysts in ~70%; Sjögren/HIV context
PPFEBiapical pleural thickeningDense biapical consolidation + traction bronchiectasis + platythoraxSubpleural, upper lobesDeep sternal notch; platythorax; posterior tracheal deviation
DAD (AIP)Bilateral diffuseGGO + consolidation, lobular sparing → traction bronchiectasisBilateral diffuseRapid ARDS-like progression; hyaline membranes histologically
SarcoidosisBHL ± parenchymal nodulesPerilymphatic nodules (1-5mm) along bronchovascular bundles + fissuresUpper/mid lobe, perihilarGalaxy sign; perilymphatic; BHL; air trapping
AsbestosisBasal reticular + pleural plaquesLower lobe reticular/honeycombing + pleural plaquesLower lobe, subpleuralPleural plaques = diagnostic clue; similar to UIP pattern
SilicosisUpper lobe nodulesUpper lobe nodules (perilymphatic); PMF massesUpper lobeEggshell calcification of nodes; PMF in advanced disease
LAMNormal or hyperinflatedBilateral uniform thin-walled round cystsDiffuse, uniform (no subpleural predominance)Young women; no fibrosis; chylothorax; TSC2 mutations
LCH (PLCH)Upper lobe nodules/cystsUpper/mid lobe bizarre-shaped cysts ± centrilobular nodulesUpper/mid lobe (spares bases)Irregular/bizarre cysts; smoker; nodules cavitate → cysts
Chronic EosinophilicPeripheral consolidationPeripheral consolidation + GGOUpper/mid lobe, peripheral"Photographic negative of pulmonary edema"; peripheral
RA-ILDBasal reticularUIP or NSIP pattern; pleural effusions; nodulesLower lobe, subpleuralPleural involvement; rheumatoid nodules may cavitate
SSc-ILDGGO + reticular basalFibrotic NSIP pattern; dilated esophagus on CTLower lobe, subpleuralDilated esophagus = key clue on HRCT
COP (CTD)VariableConsolidation + GGO; NSIP overlapPeribronchovascularAssociated CTD features; NSIP+OP overlap common

FLOWCHART 3: UIP/IPF Decision Tree (2018 ATS/ERS/JRS/ALAT + Fleischner 2018)

Patient with suspected IPF
(age >60, male, smoker, no identified cause)
                │
                ▼
           HRCT CHEST
                │
    ┌───────────┼───────────────────┐
    ▼           ▼                  ▼
TYPICAL UIP  PROBABLE UIP    INDETERMINATE    ALTERNATIVE
                               for UIP         DIAGNOSIS
    │           │                  │               │
Subpleural  Subpleural       Subtle reticular  Nodules, cysts,
bibasal     bibasal          ± mild GGO       consolidation,
reticular   reticular        No dominant       upper predominant
+           + traction       pattern           peribronchovascular
HONEYCOMB  bronchiectasis
+ traction  NO honeycomb
    │           │                  │               │
    ▼           ▼                  ▼               ▼
No biopsy    Integrate        Consider        Consider
needed      clinical prob.    biopsy         alternative
(>90%       (82-94% UIP      ↓               diagnosis
confidence) at histology)
                │           SLB / TBLC      (HP, NSIP, CTD,
            If low prob.    shows UIP?       sarcoid, etc.)
            → consider      ↓
            biopsy          Yes → IPF
                            No → Alternative

CT IMAGE GALLERY

UIP/IPF - Typical Pattern

Subpleural bibasal honeycombing with reticular changes and traction bronchiectasis, "propeller blade" distribution on sagittal
Typical UIP/IPF - subpleural honeycombing, reticular pattern, traction bronchiectasis at lung bases; sagittal showing propeller blade peripheral distribution

UIP/IPF - Probable Pattern

Subpleural basal reticulation + peripheral traction bronchiolectasis, NO honeycombing. Note bronchiolectasis originating at posterior costophrenic sulcus (sagittal)
Probable UIP - subpleural reticulation with peripheral traction bronchiolectasis, no honeycombing, characteristic origin at posterior costophrenic sulcus

Honeycombing vs Mimics - Critical Comparison

Panel showing: (A-C) true honeycombing - thick-walled, stacked, subpleural with fibrotic features; (D) paraseptal emphysema - thin-walled single layer; (E) LAM - scattered round cysts, no fibrosis; (F) cystic bronchiectasis - central, tubular
Honeycombing vs mimics - comparison of true honeycombing with paraseptal emphysema, LAM cysts, and cystic bronchiectasis

DIP (now AMP - Alveolar Macrophage Pneumonia)

A: Bilateral lower lobe GGO with mild reticulation; B: Progression to established fibrosis 2 years later
DIP/AMP - HRCT showing bilateral lower lobe ground-glass opacification with mild reticulation, progressing to fibrosis

Sarcoidosis

A: Perilymphatic nodules along fissures; B: Galaxy sign (arrow) - cluster of micronodules; C: Sagittal - upper lobe traction bronchiectasis and volume loss in fibrotic sarcoidosis
Sarcoidosis HRCT - perilymphatic nodules along fissures, galaxy sign, upper lobe fibrosis and traction bronchiectasis on sagittal

TABLE 4: Chest X-Ray Pattern → Differential Diagnosis

(Goldman-Cecil Medicine, Table 80-3)
CXR FindingKey Differential Diagnoses
Decreased lung volumesIPF, NSIP, DIP/AMP, CTD-ILD, asbestosis, drug-ILD
Increased/preserved volumesIPF+emphysema, LCH, LAM, sarcoidosis, HP, RB-ILD
MicronodulesHP, sarcoidosis, RB-ILD, infection
HoneycombingIPF, fibrotic NSIP, CTD-ILD, asbestosis, chronic HP
Fleeting/migratory infiltratesCOP, HP, EGPA, ABPA, Löffler syndrome
Recurrent infiltratesCOP, chronic eosinophilic pneumonia, drug/radiation ILD
Pleural diseaseCTD, asbestosis, LAM, sarcoidosis, malignancy, radiation
PneumothoraxLCH, LAM, tuberous sclerosis, neurofibromatosis
Hilar/mediastinal adenopathySarcoidosis, silicosis, LIP, berylliosis, malignancy
Upper lobe predominanceSarcoidosis, HP, LCH, silicosis, ankylosing spondylitis, PPFE
Lower lobe predominanceIPF, fibrotic NSIP, CTD-ILD, asbestosis, chronic HP
Peripheral distributionIPF, NSIP, COP, chronic eosinophilic pneumonia
Normal CXRCellular NSIP, RB-ILD, HP, sarcoidosis (~10% of ILD)

TABLE 5: Radiological Features of IIPs (2025 ERS/ATS Table 2 - Ryerson et al.)

PatternCT Radiological FeaturesDistribution
UIPReticulation, peripheral traction bronchiectasis, honeycombingSubpleural, lower lung predominant
NSIP (fibrotic)GGO + fine reticulation + traction bronchiectasis; no honeycombingLower lobe, subpleural sparing in ~50%
NSIP (non-fibrotic)GGO, minimal reticulation, no traction bronchiectasisLower lobe, subpleural sparing
BIP (non-fibrotic)Centrilobular GGO nodules, mosaic attenuation, lobular air trappingDiffuse
BIP (fibrotic)Peribronchovascular GGO, traction bronchiectasis, mosaic, three-density signDiffuse axial and craniocaudal
DADBilateral confluent GGO ± subtle subpleural distortionBilateral diffuse
PPFEBiapical dense consolidation + pleural thickening + traction bronchiectasis + architectural distortionUpper lobe, subpleural
LIPGGO + thin-walled cysts (70%) + centrilobular/subpleural nodulesBilateral, patchy or diffuse
OP (COP)Consolidation + GGO; perilobular pattern; halo sign; reversed halo sign; air bronchogramsSubpleural or peribronchial, lower lobe
RB-ILDPatchy poorly defined centrilobular GGO nodularityUpper lobe predominant
AMP (was DIP)Patchy/confluent GGO ± smooth reticulation ± cysts ± emphysema ± traction bronchiectasisMid-to-lower lung; variable upper

TABLE 6: Combined Patterns and Clinical Differential Diagnoses

(Ryerson et al. 2025, Table 4)
Dominant PatternCo-existing PatternCommon Diagnoses
UIPNSIPIPF, CTD-ILD, HP
UIPBIPHP, CTD-ILD, coexistent airway injury
UIPPPFECombined IPF + PPFE, CTD-ILD
UIPDADAcute exacerbation of IPF, CTD-ILD
UIPAMPIPF + smoking-related ILD
NSIPUIPIPF, CTD-ILD, HP
NSIPOrganising PneumoniaCTD-ILD, post-DAD, HP, drug reaction
NSIPBIPHP, CTD-ILD
NSIPLIPCTD-ILD, drug-induced, post-viral (HIV, EBV)
NSIPPPFEIdiopathic PPFE, CTD-ILD
BIPOrganising PneumoniaCTD-ILD, HP
BIPUIPHP
BIPNSIPHP, CTD-ILD
OPNSIPPost-infection, CTD-ILD, HP, drug reaction
OPUIPCTD-ILD, acute exacerbation of IPF

TABLE 7: Cystic Lung Diseases - Differential Diagnosis

FeatureUIP HoneycombingLAMLCHLIPBHDPPFE (late)
Cyst shapeClustered, round/polygonalRound, uniformBizarre, irregularRoundRoundN/A (consolidation)
WallThickThinThin to moderateThinThin-
DistributionSubpleural, bibasalDiffuse uniformUpper/mid; spares basesBilateralBilateralBiapical
Surrounding fibrosisYesNoNo (early)MinimalNoYes
Associated findingsTraction bronchiectasis, reticulationNormal lung, chylothoraxNodules (early), emphysemaGGO, centrilobular nodulesRenal tumorsPleural thickening
PopulationElderly male smokerYoung womenSmokerSjögren, HIVGeneticAny

TABLE 8: Disease Behaviour and Prognosis

Behaviour CategoryPatternsImplication
Progressive fibrosingUIP/IPF, Fibrotic NSIP, Fibrotic BIP/HP, PPFAntifibrotics (nintedanib, pirfenidone) indicated; poor prognosis
Reversible / stableCellular NSIP, Non-fibrotic BIP/HP, COPImmunomodulators (steroids); often improves
VariableAMP, LIP, RB-ILDDepends on cause and degree of fibrosis
Acute / life-threateningDAD/AIP, Acute HP, AEPICU-level care; corticosteroids

FLOWCHART 4: Honeycombing vs Mimic Decision Tree

SUBPLEURAL CYSTS SEEN ON HRCT
              │
    ┌─────────┴──────────┐
    ▼                    ▼
Thick-walled?          Thin-walled?
Stacked layers?              │
Other fibrosis signs?   ┌────┴────────────────┐
    │                   ▼                     ▼
   YES              Diffuse,           Subpleural,
    │               uniform,           single layer,
    ▼               round cysts        no fibrosis
TRUE                    │                    │
HONEYCOMBING            ▼                    ▼
(UIP/IPF,           ┌───┴───┐           Paraseptal
CTD-ILD,            │       │           Emphysema
asbestosis)        LAM    LIP/LCH
                  (women) (smokers/
                           CTD)

Quick Reference Card: HRCT Spot Diagnosis

If you see this...Think of...
Bibasal subpleural honeycombing + traction bronchiectasisUIP/IPF
Bibasal GGO + reticulation + subpleural sparingNSIP
Peribronchovascular consolidation + reversed halo signCOP
Perilymphatic nodules + bilateral hilar adenopathySarcoidosis
Centrilobular nodules + mosaic + air trappingHP/BIP
Three-density sign (high/normal/low)Fibrotic BIP/HP
Upper lobe bizarre cysts + centrilobular nodulesLCH
Uniform diffuse thin-walled round cysts in young womanLAM
Diffuse GGO + cysts (70%) + Sjögren/HIVLIP
Biapical dense consolidation + platythoraxPPFE
Galaxy sign (nodule cluster)Sarcoidosis
Peripheral consolidation "photographic negative of edema"Chronic eosinophilic pneumonia
Lower lobe fibrosis + pleural plaquesAsbestosis
Upper lobe nodules + eggshell node calcificationSilicosis
Dilated esophagus + lower lobe GGO/reticulationScleroderma-ILD (SSc)
Diffuse bilateral GGO + rapid ARDS-like onsetAIP/DAD

Sources: Ryerson et al. ERS/ATS 2025 Statement (Eur Respir J 2025:2500158); Grainger & Allison's Diagnostic Radiology (9780323760751); Goldman-Cecil Medicine (9780323930345); Murray & Nadel's Textbook of Respiratory Medicine (9780323655873)
This is a shared conversation. Sign in to Orris to start your own chat.